getRx
getRx is a mobile-first, DEA-compliant e-prescribing platform that lets individual prescribers write and send standard and controlled (Schedule II-V) prescriptions from an iPhone to a nationwide pharmacy network, with subscription pricing at $99-$199 per prescriber per month.
- Company typePrivate
- Founded2026
- HeadquartersMurfreesboro, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What getRx does
getRx is a mobile-first electronic prescribing platform that connects licensed prescribers, patients, and pharmacies, enabling prescriptions to be written from an iPhone and delivered to a pharmacy in under 60 seconds. The platform is built around DEA 21 CFR Part 1311 compliance and DirectTrust certification, supporting Schedule II-V controlled substance e-prescribing with biometric two-factor authentication via Authy, identity verification through Exostar, DEA registration cross-referencing via DEA Lookup, and digital certificates issued by DigiCert. End-to-end encryption and HIPAA-grade controls apply to every prescription, message, and credential sent through the system, which connects to more than 55,000 US pharmacies via fax for standard medications and electronically to Walgreens, Albertsons, and Costco for controlled substances.
The company operates on a per-prescriber subscription model with two tiers: Professional at $99/month including 100 free prescriptions, and Professional Plus at $199/month including 300 free prescriptions, priority support, and a DirectTrust certified workflow. Onboarding is self-serve, with prescribers completing a roughly five-minute flow using an NPI, DEA number, and photo ID; a 30-day free trial is offered to the first 100 prescribers. getRx targets four primary segments - veterinarians, plastic surgeons, traveling physicians, and dentists - where controlled-substance prescribing is frequent and traditional phone-based workflows create friction. The platform was founded by Dr. Dan Rudd, M.D., an internal medicine physician with 30+ years in practice at Cedar Grove Medical Associates, and Edward A. Hadley, a healthcare attorney at Aero Legal Advocates; the company is bootstrapped, headquartered in Smyrna, Tennessee, and operates with a 1-10 person team across all 50 US states.
Operationally, getRx reports more than 12,847 prescriptions sent through the platform to date and positions itself as the first truly mobile-first DEA-compliant e-prescribing app. Strategic focus in 2026 has been on the controlled-substance relaunch, the DirectTrust accreditation, expanding controlled-substance pharmacy partners beyond the initial three chains, and seeding the funnel through a free-trial PLG motion.
getRx firmographics
Firmographics- Name
- getRx
- Legal name
- getRx
- Website
- https://home.getrx.com
- Company type
- Private
- Founded year
- 2026
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- getRx is a mobile-first, DEA-compliant e-prescribing platform that lets individual prescribers write and send standard and controlled (Schedule II-V) prescriptions from an iPhone to a nationwide pharmacy network, with subscription pricing at $99-$199 per prescriber per month.
- Ownership category
- akta.pro rank
getRx industry classification
Industry- Product category
- E-Prescribing Software
- akta.pro primary industry
- ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history) (HLALAIAD)
- akta.pro secondary industry
- ePrescribing Networks, Routing & Provider Enablement (HLACAKAA)
Keywords
Where getRx is headquartered
LocationHeadquarters
- HQ city
- Murfreesboro
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
getRx business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Prescriber Subscription (Professional): Monthly subscription at $99/month per prescriber. Includes 100 free prescriptions per month, iPhone prescribing, web patient management, pharmacy and drug database, and controlled substance support (Schedule II-V). Additional prescriptions beyond the free tier are presumably billable. Patients use the platform for free.
- Prescriber Subscription (Professional Plus): Monthly subscription at $199/month per prescriber. Includes 300 free prescriptions per month, all Professional features, priority support, and Direct Trust certified workflow. Additional prescriptions beyond the free tier are presumably billable.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Professional plan: $99/month, 100 prescriptions free/month |
| Subscription | Monthly | Professional Plus plan: $199/month, 300 prescriptions free/month |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels2 records
getRx product offering
Product offeringCore offering
getRx is a mobile-first electronic prescribing platform that lets licensed prescribers write and send prescriptions, including DEA-controlled Schedule II–V substances, directly from an iPhone in under 60 seconds. The service is delivered through a native iOS app for prescription writing and a web portal for patient and profile management, with integrated Exostar identity verification, DEA Lookup registration cross-reference, DigiCert digital certificates, and Authy biometric two-factor authentication. Prescriptions are routed in real time to more than 55,000 U.S. pharmacies (fax) and electronically to Walgreens, Albertsons, and Costco for controlled substances, under DEA 21 CFR Part 1311, HIPAA, and DirectTrust compliance.
Product overview
getRx is a unified mobile prescription platform consisting of two integrated user platforms: getRx for Prescribers (iPhone app for licensed medical professionals to write and send prescriptions) and getRx for Patients (companion platform for patients to communicate with prescribers and direct prescriptions to pharmacies). The platform supports standard and controlled substance prescriptions (Schedule II-V) with full DEA 21 CFR Part 1311 compliance. The offering is delivered as a standalone mobile and web platform with two pricing tiers (Professional at $99/month and Professional Plus at $199/month), not as an add-on to existing EMR systems. Prescriptions are sent via fax to 55,000+ pharmacies nationwide for standard medications, and exclusively to Walgreens, Albertsons, and Costco for controlled substances.
Differentiator
Problem solved
Functional benefit
Brands
- getRx for Patients: Platform for patients to communicate with prescribers and direct prescriptions to a pharmacy of their choosing
- getRx for Prescribers
Products and services
- getRx for Prescribers Mobile prescription platform for licensed medical professionals with DEA prescribing authority to write and send standard and controlled (Schedule II–V) prescriptions directly from an iPhone app, with identity verification via Exostar, DEA registration cross-reference via DEA Lookup, and digital certificates via DigiCert. Web portal is included for patient upload, profile management, and prescription history review. Delivered as a subscription service per prescriber.
- getRx for Patients Patient-facing companion platform that lets patients communicate with their prescriber and direct prescriptions to the pharmacy of their choosing. Offered to patients free of charge as part of the getRx prescribing workflow.
Quantifiable outcome
- Prescription completion time reduced to under 60 seconds average (vs. 45-minute phone holds traditional workflow)
- +2 more outcomes
Companies that use getRx
Customer profileSegments4 records
Ideal customer profiles5 records
getRx technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature7 records
getRx partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- WalgreenscoreControlled substance e-prescribing partner. getRx sends DEA-compliant controlled substance prescriptions electronically to Walgreens pharmacies. Walgreens is one of only three pharmacy chains currently enabled for controlled substance e-prescribing on the platform (along with Albertsons and Costco). More controlled-substance partners expected to come online in 2026.
- AlbertsonscoreControlled substance e-prescribing partner. getRx sends DEA-compliant controlled substance prescriptions electronically to Albertsons pharmacies. One of only three pharmacy chains currently enabled for controlled substance e-prescribing on the platform. More partners expected in 2026.
- CostcocoreControlled substance e-prescribing partner. getRx sends DEA-compliant controlled substance prescriptions electronically to Costco pharmacies. One of only three pharmacy chains currently enabled for controlled substance e-prescribing on the platform. More partners expected in 2026.
- ExostarcoreThird-party identity verification provider integrated into getRx for Prescribers. Exostar compares user information to regulated data sources, authenticates government-issued identification, uses liveness detection via device camera to verify user identity, and verifies personal history answers. Core component of prescriber identity verification workflow.
- DEA LookupcoreThird-party service that cross-references verified user information and DEA registration number with active and valid DEA license records. Used after Exostar verification to confirm prescriber DEA registration validity before issuing digital certificate.
- DigiCertcoreDigital certificate provider integrated into getRx for Prescribers. Issues digital certificates to verified prescribers after DEA Lookup confirmation. Certificates authenticated for two years before requiring re-authentication.
- AuthycoreTwo-factor authentication provider used for every prescription login and controlled substance prescription signing. getRx uses Authy for 2FA, exceeding DEA EPCS requirements for controlled substances. Integrated throughout the prescription workflow.
- DirectTrustcoreDirectTrust-certified e-prescribing platform for controlled substances. getRx holds DirectTrust certification accreditation for controlled substance e-prescribing. Direct Trust certified workflow included in Professional Plus plan.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
getRx competitors and assessment
Company assessmentBroad incumbents
- eClinicalWorks: eClinicalWorks is a major ambulatory EHR that ships integrated e-prescribing with EPCS support to a large installed base of small and mid-sized practices. It is a structural threat to standalone tools like getRx in the same small-practice buyer profile.
- DrFirst: DrFirst is a long-established e-prescribing and medication management vendor offering EPCS-certified workflows used by hospitals, health systems, and EMR vendors. It competes with getRx in controlled-substance e-prescribing but operates at much larger scale and across more enterprise buyers.
- Surescripts: Surescripts operates the dominant U.S. e-prescribing network connecting prescribers, pharmacies, and payers. While it is more of a network/infrastructure layer than a UI, it is the indirect incumbent whose pharmacy and payer connectivity sets the bar getRx must clear.
- Epic Systems: Epic is the dominant enterprise EHR and ships fully integrated e-prescribing with EPCS to large hospital systems and academic medical centers. It is the long-tail enterprise competitor that defines what integrated prescribing looks like and against which any standalone e-prescribing tool must justify itself.
- Veradigm (formerly Allscripts): Veradigm is a large EHR/PM vendor with embedded e-prescribing and EPCS workflows used across hospitals and ambulatory practices. As a broad incumbent it pressures standalone tools like getRx by bundling e-prescribing inside the system of record.
Direct peers
- RxNT: RxNT is a standalone e-prescribing and EHR vendor with EPCS certification serving small practices and specialty groups. It overlaps getRx on the small/individual prescriber segment and on the standalone (non-EMR-bundled) positioning.
- NewCrop: NewCrop provides electronic prescribing and medication management software, including EPCS, that is integrated into partner EHRs and is also offered standalone. It competes with getRx in the small-practice and specialty prescribing market.
- DoseSpot: DoseSpot is a direct e-prescribing competitor with a strong footprint in dental, veterinary, and specialty practice EMRs, and offers DEA-compliant EPCS controlled-substance prescribing. It is the most directly comparable product to getRx in target segments and pricing model.
- iPrescribe (by Inphonix): iPrescribe is a mobile-first e-prescribing app targeting individual prescribers with controlled-substance support. It is the closest direct competitor to getRx's iOS-native, prescriber-self-serve model.
Emerging players
- Practice Fusion (Veradigm): Practice Fusion is a cloud-based EHR with embedded EPCS e-prescribing, popular with independent practices. Although now part of Veradigm, it remains relevant as a low-cost, cloud-first prescribing experience competing for the same solo prescriber.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
getRx social profiles
Digital presencegetRx compliance and trust
Trust signalCompliance3 records
getRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
getRx leadership team
Management profileNumber of profiles
Profiles2 records
getRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
getRx M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about getRx
What does getRx do?
getRx is a mobile-first electronic prescribing platform that lets licensed prescribers write and send prescriptions, including DEA-controlled Schedule II–V substances, directly from an iPhone in under 60 seconds. The service is delivered through a native iOS app for prescription writing and a web portal for patient and profile management, with integrated Exostar identity verification, DEA Lookup registration cross-reference, DigiCert digital certificates, and Authy biometric two-factor authentication. Prescriptions are routed in real time to more than 55,000 U.S. pharmacies (fax) and electronically to Walgreens, Albertsons, and Costco for controlled substances, under DEA 21 CFR Part 1311, HIPAA, and DirectTrust compliance.
Is getRx a public or private company?
getRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was getRx founded?
getRx was founded in 2026. It employs 1 to 10 people.
Where is getRx based?
getRx is headquartered in Murfreesboro, United States, in the North America region.
How does getRx make money?
Two revenue lines are on record. Prescriber Subscription (Professional) is the primary driver. The others are prescriber Subscription (Professional Plus).
Who are getRx's main competitors?
Broad incumbents on record are eClinicalWorks, DrFirst, Surescripts, Epic Systems and Veradigm (formerly Allscripts). Direct peers are RxNT, NewCrop, DoseSpot and iPrescribe (by Inphonix). Practice Fusion (Veradigm) is listed as an emerging player.
Does getRx have an API?
No public API is recorded for getRx.
What industry is getRx in?
getRx's product category is E-Prescribing Software. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history), with a secondary code of HLACAKAA, ePrescribing Networks, Routing & Provider Enablement.